EMA Starts Rolling Review Of CureVac’s COVID-19 Vaccine

 
• By Vibha Sharma

CureVac has submitted the pre-clinical data package for its COVID-19 vaccine to the European Medicines Agency, which will be reviewing the data on a rolling basis. 

MALLORCA/SPAIN- November 21 2020: CureVac research Coronavirus (Covid 19) vaccine. Row of vaccine bottles with blurred CureVac company logo on background.
CureVac’s COVID-19 Vaccine Can Be Stored In Fridge For Three Months • Source: Shutterstock

The European Medicines Agency has started a rolling review of German biotech CureVac’s mRNA COVID-19 vaccine, CVnCoV, which is currently in late-stage clinical testing.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography